stock & financial message boards
  Login  |  Register |  Site Map  |  Blogs |  Recent Activity  |  Members  | Glossary
Ticker/Industry
  Joined Today: 0

« Previous | Next » | All Messages |  OISI Message Board Home | recommend post |  Ignore Poster

Message #9
From: Stock News Bot
Date: November 2, 2005 02:30:00 AM

OISI News Ophthalmic Imaging Systems Announces Record Third Quarter Results; Company Reports 58% Increase in Net Income and 24% Increase in Revenues; 16th Consecutive Profitable Quarter

SACRAMENTO, Calif.--(BUSINESS WIRE)--Nov. 2, 2005--Ophthalmic Imaging Systems (OIS) (OTCBB:OISI) today reported record financial results for the third quarter ended September 30, 2005.

The Company reported net revenues of $3,246,000 for the third quarter of 2005 compared with net revenues of $2,615,000 for the third quarter of 2004, an increase of 24%. Net income for the third quarter of 2005 climbed 58% to $516,000, or $0.03 earnings per basic and diluted share, compared with net income of $327,000, or $0.02 earnings per basic and diluted share, for the third quarter of 2004.

For the first nine months of 2005, the Company reported net revenues of $9,036,000 compared with net revenues of $7,415,000 for the first nine months of 2004, an increase of 22%. Net income for the first nine months of 2005 climbed 55% to $1,256,000, or $0.08 earnings per basic and diluted share, compared with net income of $811,000, or $0.06 per basic share and $0.05 per diluted share, for the first nine months of 2004.

"OIS continues to successfully execute its growth strategy. Our ability to significantly increase sales of our digital imaging systems and informatics products led to substantial growth of 58% in net income in the third quarter of 2005 as compared to Q3 2004," stated Gil Allon, Chief Executive Officer of the Company. "We are pleased by the performance of our Ophthalmology Office(TM) product line and anticipate the revenues generated by this activity to steadily increase going forward as our sales and marketing initiatives continue to increase market awareness to the economical and operational benefits resulting from the use of these products."

Mr. Allon concluded: "We continue to focus on technical innovations with advanced new products such as our OIS WinStation 11K(TM) System, WinStation XP(TM) Version 10.3 Software, WinStation Manager(TM) and Ophthalmology Office(TM) Retinal Templates, which were released at this year's annual American Academy of Ophthalmology (AAO) conference that took place last month in Chicago. We were very encouraged during the AAO meeting by the very positive response of the ophthalmic community to the new products and we believe these products will help us to further strengthen our leading position in the ophthalmology market."

About Ophthalmic Imaging Systems

Ophthalmic Imaging Systems, a majority-owned subsidiary of MediVision, is the leading provider of ophthalmic digital imaging systems. The Company designs, develops, manufactures and markets digital imaging systems and informatics solutions for the eye care market. With over twenty years in the ophthalmic imaging business, the Company has consistently introduced new, innovative technology. The Company, together with MediVision, co-market and support their products through an extensive network of dealers, distributors, and direct representatives.

                      OPHTHALMIC IMAGING SYSTEMS
                        Selected Financial Data
                  Condensed Statements of Operations

                         THREE MONTHS ENDED      NINE MONTHS ENDED
                            SEPTEMBER 30,           SEPTEMBER 30,
                          2005        2004        2005        2004
                       ----------- ----------- ----------- -----------
                       (UNAUDITED) (UNAUDITED) (UNAUDITED) (UNAUDITED)
NET REVENUES           $3,246,216  $2,614,798  $9,035,820  $7,414,907
COST OF SALES           1,249,701   1,053,576   3,625,713   2,925,522
                       ----------- ----------- ----------- -----------
GROSS PROFIT            1,996,515   1,561,222   5,410,107   4,489,385

  SALES AND MARKETING     781,521     641,828   2,195,917   1,997,834
  GENERAL AND
   ADMINISTRATIVE         360,291     290,912     998,922     796,716
  RESEARCH AND
   DEVELOPMENT            327,501     242,847     835,313     720,033
                       ----------- ----------- ----------- -----------
    TOTAL OPERATING
     EXPENSES           1,469,313   1,175,587   4,030,152   3,514,583
                       ----------- ----------- ----------- -----------
INCOME FROM OPERATIONS    527,202     385,635   1,379,955     974,802
INTEREST AND OTHER
 EXPENSE, NET               6,378     (58,922)    (97,240)   (163,590)
                       ----------- ----------- ----------- -----------
NET INCOME BEFORE
 INCOME TAXES             533,580     326,713   1,282,715     811,212
INCOME TAXES               17,200           -      26,224           -
                       ----------- ----------- ----------- -----------
NET INCOME               $516,380    $326,713  $1,256,491    $811,212
                       =========== =========== =========== ===========

SHARES USED IN THE
 CALCULATION OF BASIC
 NET INCOME PER SHARE  15,263,798  14,975,014  15,125,515  14,683,620
BASIC NET INCOME PER
 SHARE                      $0.03       $0.02       $0.08       $0.06
                       =========== =========== =========== ===========
SHARES USED IN THE
 CALCULATION OF    
 DILUTED NET INCOME
 PER SHARE             16,427,843  15,981,937  16,295,525  15,716,087
DILUTED NET INCOME PER
 SHARE                      $0.03       $0.02       $0.08       $0.05
                       =========== =========== =========== ===========

Statements in this press release which are not historical data are forward-looking statements which involve known and unknown risks, uncertainties, or other factors not under the Company's control, which may cause actual results, performance, or achievements of the Company to be materially different from the results, performance, or other expectations implied by these forward-looking statements. These factors include, but are not limited to, those detailed in the Company's periodic filings with the Securities and Exchange Commission.

« Previous | Next » | All Messages |  OISI Message Board Home | Ignore Poster